Cell Reports MethodsBiochemistryPeer-reviewed journal article
CRISPR gene and transcriptome engineering (CRISPRgate) improves loss-of-function genetic screening approaches
Jannis StadageriD, Chiara BernardiniiD, Laura HartmanniD, Henrik May, Jessica Wiepcke, Monika Kuban, Zeynab NajafovaiD, Steven A. JohnseniD, Stefan LegewieiD, Franziska R. TraubeiD, Julian JudeiD, Philipp RathertiD
- Citations
- 5
- FWCI
- 1.20
- Field percentile
- top 24%
Abstract
The CRISPR/Cas9 technology has revolutionized genotype-to-phenotype assignments through large-scale loss-of-function (LOF) screens. However, limitations like editing inefficiencies and unperturbed genes cause significant noise in data collection. To address this, we introduce CRISPR Gene and Transcriptome Engineering (CRISPRgate), which uses two specific sgRNAs to simultaneously repress and cleave the target gene within the same cell, increasing LOF efficiencies and reproducibility. CRISPRgate outperforms conventional CRISPRko, CRISPRi, or CRISPRoff systems in suppressing challenging targets and regulators of cell proliferation. Additionally, it efficiently suppresses modulators of EMT and impairs neuronal differentiation in a human iPSC model. In a multiplexed chromatin-focused phenotypic LOF screen, CRISPRgate exhibits improved depletion efficiency, reduced sgRNA performance variance, and accelerated gene depletion compared to individual CRISPRi or CRISPRko, ensuring consistency in phenotypic effects and identifying more significant gene hits. By combining CRISPRko and CRISPRi, CRISPRgate increases LOF rates without increasing genotoxic stress, facilitating library size reduction for advanced LOF screens. MotivationThe CRISPR technology (CRISPRko/CRISPRi) enables the specific depletion of target genes with fewer off-target effects, facilitating precise investigations of gene function. Despite its benefits, CRISPR applications have limitations. Residual active protein expression mediated by in-frame DNA repair or alternative splicing1-8 as well as strong epigenetic regulation and difficulties in sgRNA design to the transcription start site (TSS)9-12 hinder the full potential of loss-of-function studies using CRISPRko or CRISPRi. We aimed to achieve robust target gene reduction in order to improve the reproducibility of the CRISPR technology by integrating the widely used CRISPRko and CRISPRi approaches into a single application.
- organism: human
- assay: CRISPR screen
- research focus: gene regulatory network inference
- research focus: perturbation response prediction
- approach: experimental assay
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comparative Single-Cell Profiling of CRISPR Knockout and Interference Defines Modality-Specific Strengths in Functional Genomics
Nikhil Gupta, Andy Sayer, … Alex Kalinka·bioRxiv·Aug 27, 2026
- Comparative benchmarking of CRISPRi and CasRx in standardized pluripotent stem cell platforms reveals context-dependent knockdown performance
Lu Ni, Takuya Murakami, … Kazutoshi Takahashi·bioRxiv·May 14, 2026
- Direct comparison of CRISPR knockout and interference with Perturb-seq
Laura M. Drepanos, Berta Escude Velasco, … John G. Doench·bioRxiv·Jul 4, 2026
- Optimized parameters for Cas9 CRISPR interference library design
Smriti Srikanth, Fengyi Zheng, … John G. Doench·bioRxiv·Feb 26, 2026
- Improved vectors and genome-wide libraries for CRISPR screening
Neville E Sanjana, Ophir Shalem, Feng Zhang·bioRxiv·Jun 28, 2014
- Optimized CRISPR guide RNA library cloning reduces skew and enables more compact genetic screens
Seok‐Jin Heo, Lauren D. Enriquez, … Eric D. Chow·bioRxiv·Dec 22, 2022